Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis

Abstract Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by an extensive loss of motor neurons in the primary motor cortex, brainstem, and spinal cord. Genetic studies report a high heritability of ALS. Recently, whole-exome sequencing analysis of famili...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurobiology of aging 2016, Vol.37, p.209.e17-209.e21
Hauptverfasser: Leblond, Claire S, Gan-Or, Ziv, Spiegelman, Dan, Laurent, Sandra B, Szuto, Anna, Hodgkinson, Alan, Dionne-Laporte, Alexandre, Provencher, Pierre, de Carvalho, Mamede, Orrù, Sandro, Brunet, Denis, Bouchard, Jean-Pierre, Awadalla, Philip, Dupré, Nicolas, Dion, Patrick A, Rouleau, Guy A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by an extensive loss of motor neurons in the primary motor cortex, brainstem, and spinal cord. Genetic studies report a high heritability of ALS. Recently, whole-exome sequencing analysis of familial ALS (FALS) patients allowed the identification of missense variations within the MATR3 gene. MATR3 was previously associated to distal myopathy 2 and encodes for a nuclear matrix and DNA/RNA binding protein that has been shown to interact with TDP43 in an RNA-dependent manner. Here, we assessed the MATR3 mutation frequency in French-Canadian ALS and control individuals ( nFALS  = 83, sporadic ALS [ nSALS ] = 164, and ncontrols  = 162) and showed that MATR3 mutations were found in 0%, 1.8%, and 0% of FALS, SALS, and controls, respectively. Interestingly, among the mutations identified in SALS, the splicing mutation c.48+1G>T was found to result in the insertion of 24 amino acids in MATR3 protein. These findings further support the role of MATR3 in ALS, and more studies are needed to shed more light on MATR3 proteinopathy.
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2015.09.013